Jazz Pharmaceuticals plc

NasdaqGS:JAZZ Stock Report

Market Cap: US$7.4b

Jazz Pharmaceuticals plc Company Information

Jazz Pharmaceuticals plc's employee growth, exchange listings and data sources


Key Information

  • Name: Jazz Pharmaceuticals plc
  • Ticker: JAZZ
  • Exchange: NasdaqGS
  • Founded: 2003
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$7.434b
  • Shares Outstanding: 60.45m
  • Website: https://www.jazzpharma.com

Number of Employees


Location

  • Jazz Pharmaceuticals plc
  • Waterloo Exchange
  • Fifth Floor
  • Dublin
  • Co. Dublin
  • D04 E5W7
  • Ireland


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
JAZZNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 2007
J7ZDB (Deutsche Boerse AG)YesCommon StockDEEURJun 2007
J7ZBRSE (Berne Stock Exchange)YesCommon StockCHCHFJun 2007
JAZZ NBMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJun 2007
J2AZ34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 15 REPR 1 COMBRBRLJan 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/22 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jazz Pharmaceuticals plc is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Ishan MajumdarBaptista Research
Richard SilverBarclays